A wildtype BRAF model was excluded from our analyses as it has been shown that in contrast to BRAFV600E cells, PLX4720 promotes wildtype BRAF glioma growth due to transactivation of wild type BRAF [18]. Here, BRAF is linked to central nervous system cancer.